157 related articles for article (PubMed ID: 15372067)
1. Self-inactivating retroviral vectors with improved RNA processing.
Kraunus J; Schaumann DH; Meyer J; Modlich U; Fehse B; Brandenburg G; von Laer D; Klump H; Schambach A; Bohne J; Baum C
Gene Ther; 2004 Nov; 11(21):1568-78. PubMed ID: 15372067
[TBL] [Abstract][Full Text] [Related]
2. The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors.
Higashimoto T; Urbinati F; Perumbeti A; Jiang G; Zarzuela A; Chang LJ; Kohn DB; Malik P
Gene Ther; 2007 Sep; 14(17):1298-304. PubMed ID: 17597793
[TBL] [Abstract][Full Text] [Related]
3. B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element.
Werner M; Kraunus J; Baum C; Brocker T
Gene Ther; 2004 Jun; 11(12):992-1000. PubMed ID: 15029232
[TBL] [Abstract][Full Text] [Related]
4. Enhanced transgene expression in primitive hematopoietic progenitor cells and embryonic stem cells efficiently transduced by optimized retroviral hybrid vectors.
Ketteler R; Glaser S; Sandra O; Martens UM; Klingmüller U
Gene Ther; 2002 Apr; 9(8):477-87. PubMed ID: 11948372
[TBL] [Abstract][Full Text] [Related]
5. Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.
Schambach A; Bohne J; Chandra S; Will E; Margison GP; Williams DA; Baum C
Mol Ther; 2006 Feb; 13(2):391-400. PubMed ID: 16226060
[TBL] [Abstract][Full Text] [Related]
6. Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors.
Schambach A; Mueller D; Galla M; Verstegen MM; Wagemaker G; Loew R; Baum C; Bohne J
Gene Ther; 2006 Nov; 13(21):1524-33. PubMed ID: 16763662
[TBL] [Abstract][Full Text] [Related]
7. Transgene optimization significantly improves SIN vector titers, gp91phox expression and reconstitution of superoxide production in X-CGD cells.
Moreno-Carranza B; Gentsch M; Stein S; Schambach A; Santilli G; Rudolf E; Ryser MF; Haria S; Thrasher AJ; Baum C; Brenner S; Grez M
Gene Ther; 2009 Jan; 16(1):111-8. PubMed ID: 18784749
[TBL] [Abstract][Full Text] [Related]
8. Increased in vitro and in vivo transgene expression levels mediated through cis-acting elements.
Johansen J; Tornøe J; Møller A; Johansen TE
J Gene Med; 2003 Dec; 5(12):1080-9. PubMed ID: 14661183
[TBL] [Abstract][Full Text] [Related]
9. Construction of retroviral vectors with enhanced efficiency of transgene expression.
Hahm SH; Yi Y; Lee DK; Noh MJ; Yun L; Hwang S; Lee KH
J Virol Methods; 2004 Nov; 121(2):127-36. PubMed ID: 15381349
[TBL] [Abstract][Full Text] [Related]
10. Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression.
Schambach A; Bohne J; Baum C; Hermann FG; Egerer L; von Laer D; Giroglou T
Gene Ther; 2006 Apr; 13(7):641-5. PubMed ID: 16355114
[TBL] [Abstract][Full Text] [Related]
11. Reconstituting retroviral (ReCon) vectors facilitating delivery of cytotoxic genes in cancer gene therapy approaches.
Brandtner EM; Kodajova P; Hlavaty J; Jandl G; Tabotta W; Salmons B; Günzburg WH; Hohenadl C
J Gene Med; 2008 Feb; 10(2):113-22. PubMed ID: 18076132
[TBL] [Abstract][Full Text] [Related]
12. Effect of posttranscriptional regulatory elements on transgene expression and virus production in the context of retrovirus vectors.
Hlavaty J; Schittmayer M; Stracke A; Jandl G; Knapp E; Felber BK; Salmons B; Günzburg WH; Renner M
Virology; 2005 Oct; 341(1):1-11. PubMed ID: 16054668
[TBL] [Abstract][Full Text] [Related]
13. Optimization of equine infectious anemia derived vectors for hematopoietic cell lineage gene transfer.
O'Rourke JP; Olsen JC; Bunnell BA
Gene Ther; 2005 Jan; 12(1):22-9. PubMed ID: 15550928
[TBL] [Abstract][Full Text] [Related]
14. Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.
Pluta K; Luce MJ; Bao L; Agha-Mohammadi S; Reiser J
J Gene Med; 2005 Jun; 7(6):803-17. PubMed ID: 15655804
[TBL] [Abstract][Full Text] [Related]
15. T cell-specific expression from Mo-MLV retroviral vectors containing a CD4 mini-promoter/enhancer.
Zhao-Emonet JC; Marodon G; Pioche-Durieu C; Cosset FL; Klatzmann D
J Gene Med; 2000; 2(6):416-25. PubMed ID: 11199262
[TBL] [Abstract][Full Text] [Related]
16. Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors.
Schambach A; Wodrich H; Hildinger M; Bohne J; Kräusslich HG; Baum C
Mol Ther; 2000 Nov; 2(5):435-45. PubMed ID: 11082317
[TBL] [Abstract][Full Text] [Related]
17. Development of novel efficient SIN vectors with improved safety features for Wiskott-Aldrich syndrome stem cell based gene therapy.
Avedillo Díez I; Zychlinski D; Coci EG; Galla M; Modlich U; Dewey RA; Schwarzer A; Maetzig T; Mpofu N; Jaeckel E; Boztug K; Baum C; Klein C; Schambach A
Mol Pharm; 2011 Oct; 8(5):1525-37. PubMed ID: 21851067
[TBL] [Abstract][Full Text] [Related]
18. Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS.
Zanta-Boussif MA; Charrier S; Brice-Ouzet A; Martin S; Opolon P; Thrasher AJ; Hope TJ; Galy A
Gene Ther; 2009 May; 16(5):605-19. PubMed ID: 19262615
[TBL] [Abstract][Full Text] [Related]
19. Retroviral vectors for the transduction of autoregulated, bidirectional expression cassettes.
Unsinger J; Kröger A; Hauser H; Wirth D
Mol Ther; 2001 Nov; 4(5):484-9. PubMed ID: 11708885
[TBL] [Abstract][Full Text] [Related]
20. FMEV vectors: both retroviral long terminal repeat and leader are important for high expression in transduced hematopoietic cells.
Hildinger M; Eckert HG; Schilz AJ; John J; Ostertag W; Baum C
Gene Ther; 1998 Nov; 5(11):1575-9. PubMed ID: 9930313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]